Location History:
- Utrecht, NL (2011)
- Naarden, NL (2019)
Company Filing History:
Years Active: 2011-2019
Title: Josbert Maarten Metselaar: Innovator in Pharmaceutical Compositions
Introduction
Josbert Maarten Metselaar is a notable inventor based in Naarden, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. With a total of 2 patents to his name, Metselaar's work focuses on innovative compositions that enhance therapeutic efficacy.
Latest Patents
Metselaar's latest patents include groundbreaking inventions related to liposomal corticosteroids for the treatment of inflammatory disorders in humans. The first patent describes a pharmaceutical composition comprising liposomes made from non-charged vesicle-forming lipids. These liposomes are designed to deliver a first corticosteroid in a water-soluble form, providing a fast, strong, and durable anti-inflammatory effect for at least two weeks. The treatment is effective at a dose of no more than 5 mg/kg body weight of prednisolone or an equivalent corticosteroid, administered at a frequency of no more than once every two weeks. The second patent outlines a similar pharmaceutical composition for parenteral administration, which includes liposomes with specific characteristics for site-specific treatment of inflammatory disorders.
Career Highlights
Metselaar is currently associated with Enceladus Pharmaceuticals B.V., where he continues to develop innovative solutions for inflammatory diseases. His work is characterized by a commitment to improving patient outcomes through advanced pharmaceutical formulations.
Collaborations
Metselaar collaborates with esteemed colleagues such as Marca Henriette M Wauben and Gerrit Storm, contributing to a dynamic research environment focused on pharmaceutical advancements.
Conclusion
Josbert Maarten Metselaar's contributions to the field of pharmaceuticals, particularly in the development of liposomal corticosteroids, highlight his role as an innovator dedicated to addressing inflammatory disorders. His work continues to pave the way for more effective treatments in the medical field.